Technology ID
E-334-2013-0

Methods for Detecting Syphilis Using Synthetic Antigens

Linked ID
TAB-3317
Inventors
Arnold Castro (CDC)
Victoria Pope (CDC)
William Morrill (CDC)
Lead Inventors
Arnold Castro (CDC)
Co-Inventors
Victoria Pope (CDC)
William Morrill (CDC)
Development Stages
Pre-Clinical (in vitro)
Applications
Diagnostics
Therapeutic Areas
Infectious Disease
ICs
CDC
Commercial Applications
  • For use in assays or diagnostic kits for the detection of syphilis
  • For use in in vitro research tools for studying syphilis
Competitive Advantages
  • Increased sensitivity and specificity with the synthetic VDRL antigen
  • Rapid, inexpensive method of detecting syphilis
  • Increased VDRL assay reagent stability at room temperature (68-72oF or 20-22oC) versus RPR and TRUST assays where the antigen is stored at refrigerated temperature (34-40oF or 1.5-4.5oC)

Request More Info

Licensing Contact